selexipag (Q15424759)

Selexipag (English)

3 October 2016

C₂₆H₃₂N₄O₄S

1 reference

Selexipag (English)

19 November 2016

CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3

1 reference

https://www.whocc.no/atc_ddd_index/?code=B01AC27

Selexipag (English)

19 November 2016

1.8 milligram

route of administration

oral administration

1 reference

reference URL

1 reference

14 February 2018

World Health Organisation international non-proprietary name

selexipag (English)

1 reference

selexipag (English)

medical condition treated

3 October 2016

pulmonary hypertension

1 reference

Drug Indications Extracted from FAERS

physically interacts with

2 October 2018

Prostaglandin I2 receptor

subject has role

agonist

1 reference

Open Targets Platform

https://platform.opentargets.org/drug/CHEMBL238804

14 August 2023

reference URL

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Selexipag

last update

10 November 2016

subject has role

antihypertensive drug

1 reference

InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)

Medical Subject Headings

15 March 2018

Selexipag

0 references

Identifiers

InChI

1 reference

Selexipag (English)

19 November 2016

2 references

Selexipag (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

475086-01-2

2 references

selexipag (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=475086-01-2

10 April 2021

1 reference

Selexipag (English)

3 October 2016

2 references

Selexipag (English)

19 November 2016

Reaxys registry number

11140227

1 reference

selexipag (English)

3 October 2016

mapping relation type

2 references

selexipag (English)

3 October 2016

International Chemical Identifier

InChI

InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)

1 reference

SELEXIPAG (English)

19 November 2016

2 references

inferred from InChIKey

1 reference

1 reference

ECHA Substance Infocard database

0 references

1 reference

ECHA Substance Infocard ID

100.237.916

27 December 2018

ECHA Substance Infocard ID

[No public or meaningful name is available] (English)

quotation

CAS no.: 475086-01-2 (English)

100.237.916

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.237.916

27 December 2018

Guide to Pharmacology Ligand ID

[No public or meaningful name is available] (English)

quotation

CAS no.: 475086-01-2 (English)

ATC code

B01AC27

0 references

7552

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7552

selexipag (English)

19 November 2016

1 reference

Medical Subject Headings

14 March 2018

1 reference

selexipag (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0258215

2 references

based on heuristic

inferred from InChIKey

2 references

selexipag (English)

19 November 2016

MedlinePlus drug identifier

a616031

route of administration

oral administration

0 references

a622007

route of administration

intravenous injection

0 references

NDF-RT ID

N0000192346

1 reference

selexipag (English)

19 November 2016

0 references

1 reference

1 reference